{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T23:17:51Z","timestamp":1782515871448,"version":"3.54.5"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.ajog.2005.11.051","type":"journal-article","created":{"date-parts":[[2006,3,8]],"date-time":"2006-03-08T07:21:26Z","timestamp":1141802486000},"page":"774-781","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"title":["Valacyclovir therapy to reduce recurrent genital herpes in pregnant women"],"prefix":"10.1016","volume":"194","author":[{"given":"William W.","family":"Andrews","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora F.","family":"Kimberlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Whitley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Cliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick S.","family":"Ramsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Deeter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2005.11.051_bib1","unstructured":"American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin: Clinical Management Guidelines for Obstetrician-Gynecologists. Management of herpes in pregnancy. Number 8, October 1999."},{"key":"10.1016\/j.ajog.2005.11.051_bib2","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJM199710163371601","article-title":"Herpes simplex virus type 2 in the United States, 1976 to 1994","volume":"337","author":"Fleming","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2005.11.051_bib3","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1097\/00006454-199010000-00032","article-title":"Herpes simplex virus infections","volume":"9","author":"Arvin","year":"1990","journal-title":"Pediatr Infect Dis"},{"key":"10.1016\/j.ajog.2005.11.051_bib4","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1056\/NEJM199105023241804","article-title":"Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor","volume":"324","author":"Brown","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2005.11.051_bib5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1542\/pir.7.4.119","article-title":"Neonatal herpes simplex virus infections","volume":"7","author":"Whitley","year":"1985","journal-title":"Pediatr Rev"},{"key":"10.1016\/j.ajog.2005.11.051_bib6","unstructured":"Royal College of Obstetricians and Gynaecologists (RCOG) clinical guideline: management of genital herpes in pregnancy. Number 30, March 2002."},{"key":"10.1016\/j.ajog.2005.11.051_bib7","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/0140-6736(90)92255-G","article-title":"Acyclovir in late pregnancy to prevent neonatal herpes simplex","volume":"336","author":"Stray-Pedersen","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2005.11.051_bib8","first-page":"102","article-title":"Oral acyclovir and recurrent genital herpes during late pregnancy","volume":"82","author":"Haddad","year":"1993","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2005.11.051_bib9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0029-7844(95)00357-6","article-title":"Acyclovir suppression to prevent cesarean delivery after first-episode genital herpes","volume":"87","author":"Scott","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2005.11.051_bib10","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1471-0528.1998.tb10086.x","article-title":"A randomized placebo controlled trial of suppressive acyclovir in late pregnancy in women with recurrent genital herpes infection","volume":"105","author":"Brocklehurst","year":"1998","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2005.11.051_bib11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0301-2115(00)00406-1","article-title":"Acyclovir prophylaxis in late pregnancy prevents recurrent genital herpes and viral shedding","volume":"96","author":"Braig","year":"2001","journal-title":"Eur J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2005.11.051_bib12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1155\/S106474490100014X","article-title":"Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: an open-label trial","volume":"9","author":"Scott","year":"2001","journal-title":"Infect Dis Obstet Gynecol"},{"key":"10.1016\/j.ajog.2005.11.051_bib13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1155\/S1064744902000054","article-title":"Acyclovir suppression to prevent recurrent genital herpes at delivery","volume":"10","author":"Scott","year":"2002","journal-title":"Infect Dis Obstet Gynecol"},{"key":"10.1016\/j.ajog.2005.11.051_bib14","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1067\/mob.2003.185","article-title":"A double-blind, randomized, placebo-controlled trial of acyclovir in late pregnancy for the reduction of herpes simplex virus shedding and cesarean delivery","volume":"188","author":"Watts","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2005.11.051_bib15","series-title":"Valtrex prescribing information","year":"2003"},{"key":"10.1016\/j.ajog.2005.11.051_bib16","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/S0002-9378(98)70176-0","article-title":"Pharmacokinetics of valacyclovir in late pregnancy","volume":"179","author":"Kimberlin","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2005.11.051_bib17","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1056\/NEJM199102143240703","article-title":"A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection","volume":"324","author":"Whitley","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2005.11.051_bib18","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/infdis\/171.4.857","article-title":"Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain biopsied patients and correlation with disease","volume":"171","author":"Lakeman","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ajog.2005.11.051_bib19","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1056\/NEJM198406143102402","article-title":"A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection","volume":"310","author":"Douglas","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2005.11.051_bib20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa035144","article-title":"Valacyclovir HSV Transmission Study Group. Once-daily valacyclovir to reduce the risk of transmission of genital herpes","volume":"350","author":"Corey","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2005.11.051_bib21","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1001\/jama.280.10.887","article-title":"Oral famciclovir for the suppression of recurrent genital herpes: a randomized controlled trial. Collaborative Famciclovir Genital Herpes Research Group","volume":"280","author":"Diaz-Mitoma","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2005.11.051_bib22","article-title":"A cost effectiveness analysis of acyclovir and valacyclovir prophylaxis in late pregnancy to prevent neonatal herpes","author":"Lin","year":"2006","journal-title":"Infect Dis Obstet Gynecol"},{"key":"10.1016\/j.ajog.2005.11.051_bib23","unstructured":"Lin MG, Biggio JR, Dimmitt RA, Andrews WW, Ramsey PS. A cost effectiveness analysis of acylovir and valacyclovir prophylaxis in late pregnancy to prevent neonatal herpes. Abstract presented at: 2005 Infectious Diseases Society for Obstetrics and Gynecology Annual Clinical Meeting; August 18-20, 2005; Isle of Palms, SC."},{"key":"10.1016\/j.ajog.2005.11.051_bib24","first-page":"806","article-title":"Pregnancy outcome following systemic prenatal acyclovir exposure, June 1, 1984-June 30, 1993","volume":"42","author":"Centers for Disease Control and Prevention","year":"1993","journal-title":"MMWR Morb Moral Wkly"},{"key":"10.1016\/j.ajog.2005.11.051_bib25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0002-9378(00)70506-0","article-title":"Monitoring pregnancy outcome after prenatal drug exposure through prospective registries: a pharmaceutical company commitment","volume":"182","author":"Reiff-Eldridge","year":"2000","journal-title":"Am J Obstet Gynecol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937805026141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937805026141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T10:16:35Z","timestamp":1757585795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937805026141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0002937805026141"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2005.11.051","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valacyclovir therapy to reduce recurrent genital herpes in pregnant women","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2005.11.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}